The German biotechnology company Biontech plans to develop a messenger RNA vaccine against malaria in the coming years, the pharmaceutical company announced today.
The firm plans to start a clinical trial in late 2022. An mRNA vaccine (mRNA stands for messenger ribonucleic acid.) teaches the body's…
Read More...
